Abiopharma

🔍 Groman Daniel J (Executive)

Company: Walker & Dunlop, Inc. (WD)

Report Date: 2026-03-27

Detailed Transactions and Holdings:

• Acquired 116 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-03-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 285.15 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.
• F2: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.